1
|
Sharifzadeh M, Chiniforoush TA, Sadeghi M. Design and optimizing a novel ocular plaque brachytherapy with dual-core of 103Pd and 106Ru. Phys Med 2021; 91:99-104. [PMID: 34742099 DOI: 10.1016/j.ejmp.2021.10.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/17/2021] [Revised: 09/24/2021] [Accepted: 10/05/2021] [Indexed: 10/19/2022] Open
Abstract
In recent decades, eye plaques of brachytherapy have been extensively used as primary treatment as well as a complementary treatment for ocular cancer. The purpose of this study is the development of the eye plaque brachytherapy throughout a new design of eye plaque by combining the COMS plaque and the CCB BEBIG plaque loaded by IRA1-103Pd and 106Ru, respectively. A new dual-core plaque with a diameter of 20 mm was designed in the way that the BEBIG plaque with a diameter of 20 mm loaded by 106Ru plate is attached to the COMS plaque with a diameter of 20 mm loaded by 24 of IRA1-103Pd seeds. Dose calculations for the new plaque were performed by using the MCNP5 code. Dose calculations of dual-core plaque including 103Pd seeds (gamma) and 106Ru plate (beta) were separately done for the sake of MCNP constraints in gamma and beta particle transfer simultaneously. The new dual-core plaque delivers a much higher dose rate to the tumor compared with every single plaque, while the dose rate reached to healthy tissues is slightly higher than each plaque separately. Of course, this is acceptable because the treatment time reduces and subsequently the error in radiation therapy reduces.
Collapse
Affiliation(s)
- Mohsen Sharifzadeh
- Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran
| | - Tayebeh A Chiniforoush
- Department of Medical Radiation Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran
| | - Mahdi Sadeghi
- Medical Physics Department, School of Medicine, Iran University of Medical Sciences, P.O. Box: 14155-6183 Tehran, Iran.
| |
Collapse
|
2
|
Wilby S, Palmer A, Polak W, Bucchi A. A review of brachytherapy physical phantoms developed over the last 20 years: clinical purpose and future requirements. J Contemp Brachytherapy 2021; 13:101-115. [PMID: 34025743 PMCID: PMC8117707 DOI: 10.5114/jcb.2021.103593] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2020] [Accepted: 11/13/2020] [Indexed: 12/04/2022] Open
Abstract
Within the brachytherapy community, many phantoms are constructed in-house, and less commercial development is observed as compared to the field of external beam. Computational or virtual phantom design has seen considerable growth; however, physical phantoms are beneficial for brachytherapy, in which quality is dependent on physical processes, such as accuracy of source placement. Focusing on the design of physical phantoms, this review paper presents a summary of brachytherapy specific phantoms in published journal articles over the last twenty years (January 1, 2000 - December 31, 2019). The papers were analyzed and tabulated by their primary clinical purpose, which was deduced from their associated publications. A substantial body of work has been published on phantom designs from the brachytherapy community, but a standardized method of reporting technical aspects of the phantoms is lacking. In-house phantom development demonstrates an increasing interest in magnetic resonance (MR) tissue mimicking materials, which is not yet reflected in commercial phantoms available for brachytherapy. The evaluation of phantom design provides insight into the way, in which brachytherapy practice has changed over time, and demonstrates the customised and broad nature of treatments offered.
Collapse
Affiliation(s)
- Sarah Wilby
- Department of Radiotherapy Physics, Clinical Hematology, and Oncology Centre, Portsmouth Hospitals NHS Trust, Cosham, Portsmouth, United Kingdom
- Department of Mechanical Engineering, Faculty of Technology University of Portsmouth, Portsmouth, United Kingdom
| | - Antony Palmer
- Department of Radiotherapy Physics, Clinical Hematology, and Oncology Centre, Portsmouth Hospitals NHS Trust, Cosham, Portsmouth, United Kingdom
- Department of Mechanical Engineering, Faculty of Technology University of Portsmouth, Portsmouth, United Kingdom
| | - Wojciech Polak
- Department of Radiotherapy Physics, Clinical Hematology, and Oncology Centre, Portsmouth Hospitals NHS Trust, Cosham, Portsmouth, United Kingdom
- Department of Mechanical Engineering, Faculty of Technology University of Portsmouth, Portsmouth, United Kingdom
| | - Andrea Bucchi
- Department of Mechanical Engineering, Faculty of Technology University of Portsmouth, Portsmouth, United Kingdom
| |
Collapse
|
3
|
Kron T, Lonski P, Yukihara EG. THERMOLUMINESCENCE DOSIMETRY (TLD) IN MEDICINE: FIVE 'W'S AND ONE HOW. RADIATION PROTECTION DOSIMETRY 2020; 192:139-151. [PMID: 33429435 DOI: 10.1093/rpd/ncaa212] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/14/2020] [Revised: 11/14/2020] [Accepted: 11/23/2020] [Indexed: 06/12/2023]
Abstract
Thermoluminescence dosimetry (TLD) has a long history of applications in medicine. However, despite its versatility and sensitivity its use is anecdotally diminishing, at least in part due to the complexity and work intensity of a quality TLD service. The present paper explores the role of TLD in medicine using a common inquiry methodology (5W1H) which systematically asks 'Who, What, When, Where, Why and How' to identify what role TLD could and should play in medical applications.
Collapse
Affiliation(s)
- Tomas Kron
- Department of Physical Sciences, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia
- Centre for Medical Radiation Physics, University of Wollongong, Northfields Avenue Gwynneville, NSW 2500, Australia
| | - Peta Lonski
- Department of Physical Sciences, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia
| | - Eduardo G Yukihara
- Department of Radiation Safety and Security, Paul Scherrer Institute, 5200 Villigen, Switzerland
| |
Collapse
|
4
|
Karavasilis E, Dimitriadis A, Gonis H, Pappas P, Georgiou E, Yakoumakis E. DOSE COEFFICIENTS FOR LIVER CHEMOEMBOLISATION PROCEDURES USING MONTE CARLO CODE. RADIATION PROTECTION DOSIMETRY 2016; 172:409-415. [PMID: 26656074 DOI: 10.1093/rpd/ncv492] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/27/2015] [Revised: 10/24/2015] [Accepted: 10/28/2015] [Indexed: 06/05/2023]
Abstract
The aim of the present study is the estimation of radiation burden during liver chemoembolisation procedures. Organ dose and effective dose conversion factors, normalised to dose-area product (DAP), were estimated for chemoembolisation procedures using a Monte Carlo transport code in conjunction with an adult mathematical phantom. Exposure data from 32 patients were used to determine the exposure projections for the simulations. Equivalent organ (HT) and effective (E) doses were estimated using individual DAP values. The organs receiving the highest amount of doses during these exams were lumbar spine, liver and kidneys. The mean effective dose conversion factor was 1.4 Sv Gy-1 m-2 Dose conversion factors can be useful for patient-specific radiation burden during chemoembolisation procedures.
Collapse
Affiliation(s)
- E Karavasilis
- Medical Physics Department, Medical School, University of Athens, 75 Mikras Asias Str. Goudi, Athens 11527, Greece
| | - A Dimitriadis
- Medical Physics Department, Medical School, University of Athens, 75 Mikras Asias Str. Goudi, Athens 11527, Greece
| | - H Gonis
- Radiology Department, Laiko Hospital of Athens, 17 Ag. Thoma Str. Goudi, Athens 11527, Greece
| | - P Pappas
- Radiology Department, Laiko Hospital of Athens, 17 Ag. Thoma Str. Goudi, Athens 11527, Greece
| | - E Georgiou
- Medical Physics Department, Medical School, University of Athens, 75 Mikras Asias Str. Goudi, Athens 11527, Greece
| | - E Yakoumakis
- Medical Physics Department, Medical School, University of Athens, 75 Mikras Asias Str. Goudi, Athens 11527, Greece
| |
Collapse
|
5
|
Karavasilis E, Dimitriadis A, Gonis H, Pappas P, Georgiou E, Yakoumakis E. Effective dose in percutaneous transhepatic biliary drainage examination using PCXMC2.0 and MCNP5 Monte Carlo codes. Phys Med 2014; 30:432-6. [PMID: 24374260 DOI: 10.1016/j.ejmp.2013.12.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2013] [Revised: 12/09/2013] [Accepted: 12/10/2013] [Indexed: 10/25/2022] Open
Abstract
OBJECTIVES To estimate the organ equivalent doses and the effective doses (E) in patient undergoing percutaneous transhepatic biliary drainage (PTBD) examinations, using the MCNP5 and PCXMC2 Monte Carlo-based codes. METHODS The purpose of this study is to estimate the organ doses to patients undergoing PTBD examinations by clinical measurements and Monte Carlo simulation. Dose area products (DAP) values were assessed during examination of 43 patients undergoing PTBD examination separated into groups based on the gender and the dimensions and location of the beam. RESULTS Monte Carlo simulation of photon transport in male and female mathematical phantoms was applied using the MCNP5 and PCXMC2 codes in order to estimate equivalent organ doses. Regarding the PTBD examination the organ receiving the maximum radiation dose was the lumbar spine. The mean calculated HT for the lumbar spine using the MCNP5 and PCXMC2 methods respectively, was 117.25 mSv and 131.7 mSv, in males. The corresponding doses were 139.45 mSv and 157.1 mSv respectively in females. The HT values for organs receiving considerable amounts of radiation during PTBD examinations were varied between 0.16% and 73.2% for the male group and between 1.10% and 77.6% for the female group. E in females and males using MCNP5 and PCXMC2.0 was 5.88 mSv and 6.77 mSv, and 4.93 mSv and 5.60 mSv. CONCLUSION The doses remain high compared to other invasive operations in interventional radiology. There is a reasonable good coincidence between the MCNP5 and PCXMC2.0 calculation for most of the organs.
Collapse
Affiliation(s)
- E Karavasilis
- Medical Physics Department, Medical School, University of Athens, 75 Mikras Asias Str., Goudi, 11527 Athens, Greece.
| | - A Dimitriadis
- Medical Physics Department, Medical School, University of Athens, 75 Mikras Asias Str., Goudi, 11527 Athens, Greece
| | - H Gonis
- Medical Physics Department, Laiko Hospital of Athens, 17 Ag. Thoma Str., Goudi, 11527 Athens, Greece
| | - P Pappas
- Radiology Department, Laiko Hospital of Athens, 17 Ag. Thoma Str., Goudi, 11527 Athens, Greece
| | - E Georgiou
- Medical Physics Department, Medical School, University of Athens, 75 Mikras Asias Str., Goudi, 11527 Athens, Greece
| | - E Yakoumakis
- Medical Physics Department, Medical School, University of Athens, 75 Mikras Asias Str., Goudi, 11527 Athens, Greece
| |
Collapse
|
6
|
Anjomrouz M, Sadeghi M, Haddadi A. Monte Carlo characterization of 169Yb as a high-dose-rate source for brachytherapy application by FLUKA code. J Appl Clin Med Phys 2013; 14:4298. [PMID: 23835393 PMCID: PMC5714526 DOI: 10.1120/jacmp.v14i4.4298] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2012] [Revised: 03/03/2013] [Accepted: 03/09/2013] [Indexed: 11/23/2022] Open
Abstract
Higher initial dose rate and simplifying HDR room treatment of 169Yb element among other brachytherapy sources has led to investigating its feasibility as high‐dose‐rate seed. In this work, Monte Carlo calculation was performed to obtain dosimetric parameters of 169Yb, Model M42 source at different radial distances according to AAPM TG‐43U1 and HEBD Report about HDR sources in both air vacuum and spherical homogeneous water phantom. The deposited energy resulted by FLUKA as Monte Carlo code using binning estimators around 169Yb source was converted into radial dose rate distribution in polar coordinates surrounding the brachytherapy source. The results indicate a dose rate constant of 1.14±0.04cGy.h−1.U−1 with approximate uncertainty of 0.04%, air kerma strength, 1.082±2.6E−06U.mCi−1 and anisotropy function ranging from 0.386 to 1.00 for radial distances of 0.5–10 cm and polar angles of 0°–180°. Overall, FLUKA dosimetric outputs were benchmarked with those published by Cazeca et al. via MCNP5 as one of validate dosimetry datasets related to 169Yb HDR source. As a result, it seems that FLUKA code can be applicable as a valuable tool to Monte Carlo evaluation of novel HDR brachytherapy sources. PACS number: 87.15.ak
Collapse
Affiliation(s)
- Marzieh Anjomrouz
- Medical Radiation Engineering Department, Science and Research Branch, Islamic Azad University, Tehran, Iran.
| | | | | |
Collapse
|